Mid-Year Report — WALGREEN COMPANY for WALGREEN COMPANY (2007)

Firm

WALGREEN COMPANY

Client

WALGREEN COMPANY

Income

—

Expenses

$500,000

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

Organized retail crime as related to federalizing the crime--no specific legislation introduced

Lobbyist	Covered position, as disclosed
DEBBIE GARZA	N/A
LESLIE HIGGINS	N/A
BRYAN A SCHNEIDER	N/A

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP)

Medicare/Medicaid MMM

H.R. 621 / S. 1484, Home Oxygen Patient Protection Act of 2007 as relates to removal of 36-month oxygen rental cap

Lobbyist	Covered position, as disclosed
DEBBIE GARZA	N/A
LESLIE HIGGINS	N/A
BRYAN A SCHNEIDER	N/A

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: S. 1484 (110th), H.R. 621 (110th)

Consumer Issues/Safety/Products CSP

S. 1276, Methamphetamine Production Prevention Act of 2007 as related to electronic logbooks and tracking of methamphetamine precursor chemicals, i.e. pseudoephredine; Dextromethorphan as related to age limits on sales of products containing dextromethorphan--no legislation introduced.

Lobbyist	Covered position, as disclosed
DEBBIE GARZA	N/A
LESLIE HIGGINS	N/A
BRYAN A SCHNEIDER	N/A

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE

Bills named: S. 1276 (110th)

Pharmacy PHA

S. 1082, FDA Revitalization Act of 2007 as relates to MedGuides for prescription drugs, internet pharmacy regulation, and anti-counterfeiting of prescription drugs (track and trace); Medicare Part D as related to "fix" with regards to enrollment processing period -- no legislation introduced specific to this; National Provider ID (NPI) as related to date of implementation and look to delay with Administration (CMS) and Congress--no specific legislation. Medicaid prescription drug reimbursement as related to AMP (average manufacturer's price) and FULs (federal upper limits)--no specific legislation yet introduced during this timeframe; H.R. 2567, Medicare Home Infusion Pharmacy Coverage Act of 2007 as it relates to provisions for meaningful Medicare home infusion of prescription drugs benefit; H.R.2900, FDA Amendments Act of 2007, as related to provision dealing with MedGuides required for select prescription drugs;

Lobbyist	Covered position, as disclosed
DEBBIE GARZA	N/A
LESLIE HIGGINS	N/A
BRYAN A SCHNEIDER	N/A

Contacted: Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2567 (110th), H.R. 2900 (110th), S. 1082 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.